Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41642431)
Watch
English
Antibody-based immunological therapies
scientific article published on October 1997
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
review article
1 reference
stated in
Europe PubMed Central
title
Antibody-based immunological therapies
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
main subject
immunology
1 reference
based on heuristic
inferred from title
author name string
Scott AM
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
Welt S
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
publication date
1 October 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
published in
Current Opinion in Immunology
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
volume
9
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
page(s)
717-722
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
issue
5
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
cites work
Continuous cultures of fused cells secreting antibody of predefined specificity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy for cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical promise of tumour immunology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and production of novel tetravalent bispecific antibodies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab')2 in ovarian carcinoma patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor therapy by immune recruitment with bispecific antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical development of 2B1, a bispecific murine monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The epidermal growth factor receptor as a target for therapy in breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980054-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0952-7915(97)80054-4
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
PubMed ID
9368782
1 reference
stated in
Europe PubMed Central
PubMed ID
9368782
retrieved
6 October 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
